CDT Equity Inc.
CDT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001896212
In the last 90 days, CDT Equity Inc. insiders filed 0 open-market purchases and 1 sale; 8 institutions reported holding it in 13F filings for Q2 2026, worth $94.7K in total; no superinvestor holds it.
Other share classesCDTTW
Q1 2026 vs. Q4 2025
How the institutions holding CDT Equity Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 9 | 2 | −7 |
| Shares | 32.4K | 112 | −32.3K (−99.7%) |
| Value | $41.4K | $571 | −$40.9K (−98.6%) |
New holders (0)
Institutions that held CDT Equity Inc. at the end of Q1 2026 but not at the end of Q4 2025.
None.
Sold out (7)
Institutions that held CDT Equity Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Virtu Financial LLC | 15,636 | $20.0K |
| Apollon Wealth Management, LLC | 13,431 | $17.2K |
| UBS Group AG | 635 | $813 |
| Bank of America Corp | 11 | $14 |
| BlackRock, Inc. | 9 | $12 |
| Barclays PLC | 2 | $3 |
| SBI Securities Co., Ltd. | 2 | $3 |